Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kinnate Biopharma (KNTE)
NASDAQ:KNTE
Kinnate Biopharma (KNTE) Ownership - Who Owns Kinnate Biopharma?
232 Followers
Kinnate Biopharma (KNTE) Ownership Overview
0.14% Insiders
5.82% Mutual Funds
69.31% Other Institutional Investors
24.73% Public Companies and
Individual Investors
The ownership structure of Kinnate Biopharma (KNTE) stock is a mix of institutional, retail and individual investors. Approximately 75.13% of the company’s stock is owned by Institutional Investors, 0.14% is owned by Insiders and 24.73% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 10, 2023 | Foresite Capital Management Iv, Llc >10% Owner | Bought | $4984000 |
| May 10, 2023 | James B. Tananbaum Director, >10% Owner | Bought | $4984000 |
| May 08, 2023 | Carl Gordon Director, >10% Owner | Bought | $4086235 |
| May 08, 2023 | Orbimed Advisors Llc Director, >10% Owner | Bought | $4086235 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,820,462 | Institution | 3.85% | 4,824,224 | |
| 995,008 | Institution | 2.11% | 2,636,771 | |
| 995,008 | Institution | 2.11% | 2,636,771 | |
| 351,780 | Institution | 0.74% | 932,217 | |
| 340,001 | Institution | 0.72% | 901,003 | |
| 276,687 | Institution | 0.59% | 733,221 | |
| 177,265 | Institution | 0.38% | 469,752 | |
| 104,631 | Institution | 0.22% | 277,272 | |
| 80,721 | Institution | 0.17% | 213,911 | |
| 79,300 | Institution | 0.17% | 210,145 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 995,008 | Institution | 2.11% | 2,636,771 | |
| 351,780 | Institution | 0.74% | 932,217 | |
| 340,001 | Institution | 0.72% | 901,003 | |
| 276,687 | Institution | 0.59% | 733,221 | |
| 177,265 | Institution | 0.38% | 469,752 | |
| 104,631 | Institution | 0.22% | 277,272 | |
| 80,721 | Institution | 0.17% | 213,911 | |
| 79,300 | Institution | 0.17% | 210,145 | |
| 74,845 | Institution | 0.16% | 198,339 | |
| 47,490 | Institution | 0.10% | 125,849 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 730,663 | Institution | 1.55% | 1,804,738 | |
| 264,345 | Institution | 0.56% | 652,932 | |
| 50,697 | Institution | 0.11% | 125,222 | |
| 50 | Institution | <0.01% | 152 | |
| 4 | Institution | <0.01% | 32 |
FAQ
Who Owns Kinnate Biopharma (KNTE)?
According to the latest TipRanks data, approximately 69.31% of the company's stock is held by institutional investors, 0.14% is held by insiders, and 24.73% is held by retail investors.
What percentage of Kinnate Biopharma (KNTE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 69.31% of Kinnate Biopharma (KNTE) stock is held by institutional investors.
What percentage of Kinnate Biopharma (KNTE) stock is held by retail investors?
According to the latest TipRanks data, approximately 24.73% of Kinnate Biopharma (KNTE) stock is held by retail investors.
Who owns the most shares of Kinnate Biopharma (KNTE)?
Andreas Halvorsen owns the most shares of Kinnate Biopharma (KNTE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.